- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07901335
KLF4 Epigenetic Modulation (POLYEP)
KLF4 Epigenetic Modulation During Polyps-adenoma Progression
The study investigates the epigenetic regulation of KLF4 during the progression from colorectal polyps to adenomas and carcinomas. Quantitative KLF4 methylation will be assessed in colorectal tissue samples obtained during routine colonoscopy, together with KLF4 gene expression and its correlation with methylation status in matched tissue samples. The study will also evaluate quantitative and site-specific molecular approaches for the assessment of KLF4 methylation.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Colorectal cancer is one of the most frequently diagnosed cancers worldwide. Colorectal polyps and adenomas represent precursor lesions that may undergo malignant transformation. KLF4 is a transcription factor involved in the regulation of cellular processes and has been described as having context-dependent roles in cancer development. Its activity may be regulated by epigenetic mechanisms, including DNA methylation. The purpose of this prospective observational study is to investigate the epigenetic regulation of KLF4 during the progression from colorectal polyps to adenomas and carcinomas. The primary objective is to assess quantitative KLF4 methylation across different stages of colorectal tissue progression. Secondary objectives are to investigate quantitative and site-specific molecular approaches for the assessment of KLF4 methylation and to assess KLF4 gene expression and its correlation with KLF4 methylation in matched tissue samples.
The study is monocentric and will be conducted at AUSL-IRCCS Reggio Emilia. Participants will be adults undergoing routine colonoscopy and diagnosed by the Pathology Division of AUSL-IRCCS Reggio Emilia. Only tissue samples obtained during routine diagnostic procedures and accompanied by signed informed consent will be included. The research procedures will not affect the diagnostic procedures.
Colorectal tissue samples will be processed as formalin-fixed, paraffin-embedded (FFPE) sections. Genomic DNA and total RNA will be extracted from the samples. DNA methylation will be assessed following bisulfite conversion and specific bisulfite PCR using quantitative PCR approaches. KLF4 gene expression will be assessed by real-time quantitative PCR. Molecular data will be recorded in a study database.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiesteder
-
-
-
Reggio Emilia, Italien
- Rekruttering
- Azienda USL IRCCS di Reggio Emilia
-
Kontakt:
- Raffaele Frazzi, PhD
- Telefonnummer: 0522 295777
- E-mail: raffaele.frazzi@ausl.re.it
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
The samples are represented by endoscopic specimens collected only during routine exams.
Beskrivelse
Inclusion Criteria:
- Patients undergoing routine colonoscopy
- > 18 years of age
- Diagnosed by S.C. Anatomia Patologica, AUSL-IRCCS Reggio Emilia
Exclusion Criteria:
- Concomitant diagnosis of colorectal carcinoma
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
KLF4 DNA methylation
Tidsramme: 24 months
|
Quantitative assessment of KLF4 DNA methylation in colorectal tissue samples representing different stages of colorectal polyp-adenoma-carcinoma progression. KLF4 methylation will be assessed using bisulfite conversion followed by specific PCR. |
24 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Site-specific KLF4 methylation
Tidsramme: 24 months
|
Evaluation of site-specific KLF4 DNA methylation in colorectal tissue samples using molecular approaches based on bisulfite conversion and PCR analysis. |
24 months
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 340/2026/TESS/IRCCSRE
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .